Low sodium diet or lifestyle modification and change in BP Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials Dickinson et al.53 Cochrane CENTRAL MEDLINE Embase References used to check and supplement reference list of ERT systematic review Systematic review of long term effects of advice to reduce dietary salt in adults Hooper et al.62 Cochrane CENTRAL MEDLINE Embase CAB abstracts CVRCT registry SIGLE Further search on sodium restriction and BP: Cochrane CENTRAL MEDLINE Embase Up to July 2002 References used to check and supplement reference list of ERT systematic review Topic 2. BP target and kidney outcomes Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient level meta-analysis Jafar et al.96 MEDLINE References used to check and supplement reference list of ERT systematic review Topic 3. ACE-I or ARB on CVD and CKD progression RAS blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis Balamuthusamy et al.97 OVID MEDLINE Embase References used to check and supplement reference list of ERT systematic review Angiotensin receptor blockers as anti-hypertensive treatment for patients with diabetes mellitus: meta-analysis of controlled double-blind randomized trials Siebenhofer et al.450 Cochrane CENTRAL MEDLINE Embase Cochrane Controlled Trials Register PubMed DARE NHSEED HTA References used to check and supplement reference list of ERT systematic review Topic 4. ACE-I or ARB on CKD progression Effect of inhibitors of the renin-angiotensin system and other anti-hypertensive drugs on renal outcomes: systematic review and meta-analysis Casas et al.451 Cochrane CENTRAL MEDLINE Embase References used to check and supplement reference list of ERT systematic review Topic 5. ACE-I on CKD progression in CKD without DM Angiotensin-converting enzyme inhibitors and progression of non-diabetic renal disease. 